Safety of bilateral intravitreal injections delivered in a teaching institution

Expert Opinion on Drug Delivery

Volumn 11, Issue 7, 2014, Pages 991-993

  Chao, Daniel L ^a,b   Gregori, Ninel Z ^a,b   Khandji, Joyce ^c   Goldhardt, Raquel ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Aflibercept; Anti VEGF; Bevacizumab; Bilateral intravitreal injection; Ophthalmology resident; Ranibizumab; Teaching institution; Veterans Affairs hospital

Indexed keywords

VASCULOTROPIN INHIBITOR;

DRUG ADMINISTRATION ROUTE; ENDOPHTHALMITIS; HUMAN; INFECTIOUS ENDOPHTHALMITIS; MEDICAL EDUCATION; OPHTHALMOLOGIST; PATIENT CARE; PATIENT COMFORT; PATIENT SAFETY; REVIEW; TEACHING HOSPITAL; VISUAL IMPAIRMENT;

AFLIBERCEPT; ANTI-VEGF; BEVACIZUMAB; BILATERAL INTRAVITREAL INJECTION; OPHTHALMOLOGY RESIDENT; RANIBIZUMAB; TEACHING INSTITUTION; VETERANS AFFAIRS HOSPITAL;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; EDUCATION, MEDICAL, GRADUATE; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; HOSPITALS, TEACHING; HOSPITALS, VETERANS; HUMANS; INTERNSHIP AND RESIDENCY; INTRAVITREAL INJECTIONS; OPHTHALMOLOGY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RETINAL DISEASES; UNITED STATES;

EID: 84903220999     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2014.909806     Document Type: Review

References (15)

1. Tabatabaii A, Ahmadraji A, Khodabande A, Mansouri M. Acute bilateral endophthalmitis following bilateral intravitreal bevacizumab (avastin) injection. Middle East Afr J Ophthalmol 2013;20(1):87-8
2. Falavarjani KG, Modarres M, Hashemi M, et al Incidence of acute endophthalmitis after intravitreal bevacizumab injection in a single clinical center. Retina 2013;33(5):971-4
3. Green-Simms AE, Ekdawi NS, Bakri SJ. Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol 2011;151(2):329-32
4. McCannel CA. Meta-Analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: Causative organisms and possible prevention strategies. Retina 2011;31(4):654-61
5. Gonzalez S, Rosenfeld PJ, Stewart MW, et al. Avastin Doesn't blind people, people blind people. Am J Ophthalmol 2012;153(2):196-203; e191
6. Goldberg RA, Flynn HW Jr, Miller D, et al. Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: One-year outcomes and investigative results. Ophthalmology 2013;120(7):1448-53
7. Mahajan VB, Elkins KA, Russell SR, et al. Bilateral intravitreal injection of antivascular endothelial growth factor therapy. Retina 2011;31(1):31-5
8. Davis RP, Schefler AC, Murray TG. Concomitant bilateral intravitreal anti-vegf injections for the treatment of exudative age-related macular degeneration. Clin Ophthalmol 2010;4:703-7
9. Woo SJ, Han JM, Ahn J, et al. Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance. Retina 2012;32(4):667-71
10. Lima LH, Zweifel SA, Engelbert M, et al. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy. Retina 2009;29(9):1213-17
11. Bakri SJ, Risco M, Edwards AO, Pulido JS. Bilateral simultaneous intravitreal injections in the office setting. Am J Ophthalmol 2009;148(1):66-9; e61
12. Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D 2013;13(1):1-8
13. Wykoff CC, Flynn HW Jr, Rosenfeld PJ. Prophylaxis for endophthalmitis following intravitreal injection: Antisepsis and antibiotics. Am J Ophthalmol 2011;152(5):717-19; e712
14. Bhavsar AR, Stockdale CR, Ferris FL III, et al. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics. Arch Ophthalmol 2012;130(6):809-10
15. Cheung CS, Wong AW, Lui A, et al Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 2012;119(8):1609-14